Skip to main content
. 2016 Apr 30;95:1077–1087. doi: 10.1007/s00277-016-2682-2

Fig. 4.

Fig. 4

Platelet count and dose over time for patients with ITP treated with romiplostim by self-administration status. a Platelet count over time by self-administration status. b Romiplostim dose over time by self-administration status. ITP immune thrombocytopenia, Q1 quartile 1, Q3 quartile 3